All of the following statements about trientine use in Wilson’s disease are true except :
**Core Concept**
Trientine is a chelating agent used in the management of Wilson's disease, a genetic disorder characterized by excessive accumulation of copper in the body. The drug works by binding to copper in the bloodstream and facilitating its excretion.
**Why the Correct Answer is Right**
Trientine is administered orally and is particularly useful in patients who are not responsive to penicillamine, another chelating agent used for Wilson's disease. It is also effective in reducing the levels of copper in the liver, brain, and other organs. Trientine's mechanism of action involves the formation of a stable complex with copper, which is then excreted in the urine.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, so we'll proceed to the next one.
**Option B:** This option is not provided, so we'll proceed to the next one.
**Option C:** This option is not provided, so we'll proceed to the next one.
**Option D:** This option is not provided, so we'll proceed to the next one.
**Clinical Pearl / High-Yield Fact**
It's essential to note that trientine can cause renal impairment, particularly in patients with pre-existing renal disease. Therefore, monitoring of renal function is crucial during therapy.
**Correct Answer:**